PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Assistance Publique - Hôpitaux de Paris (AP-HP), CIC Cochin Pasteur, Hôpital Cochin, Paris, France.\', \'AP-HP, Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France.\', \'Aix Marseille Université, IRD 190, INSERM 1207, Unité des Virus Emergents, UVE, IHU Méditerranée Infection, Marseille, France.\', \'Institut de Santé Publique d\'Epidémiologie et de Développement, INSERM, Bordeaux Population Health Research Center, UMR 1219, Centre d\'Investigation Clinique-Epidémiologie Clinique 1401, University of Bordeaux, Service d\'Information Médicale, CHU de Bordeaux, Pôle de Santé Publique, Bordeaux, France.\', \'INSERM U1047, Department of Infectious and Tropical Diseases, CHU Nîmes, Université Montpellier, Nîmes, France.\', \'Université de Paris, Faculté de Médecine Paris Descartes, AP-PH, Inserm, CIC Cochin Pasteur, Paris, France. Electronic address: odile.launay@aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1198-743X(21)00566-810.1016/j.cmi.2021.09.036
?:doi
?:hasPublicationType
?:journal
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 35020589
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all